What should I know about ADHD medication for adults and children?
Stimulants increase the level of the neurotransmittersdopamineandnorepinephrinein the brain.
This improves inattention, impulsivity, and hyperactivity in people with ADHD.
Paul Bradbury / Getty Images
Also, some people respond to one kind of stimulant and not another.
Also, be safe and don’t stop orchange the dosageof your medication without medical guidance.
Types of Stimulants
Stimulants can come in a number of forms, like shorter- andlonger-acting medications.
Get our printable guide for your next doctor’s appointment to help you ask the right questions.
Extended-release stimulants are those that provide a longer-lasting, continuous level of medication.
They dissolve slowly and release the drug over time.
Immediate release medications tend to only be effective for three to five hours.
Strattera is a good option for people who cannot tolerate or take a stimulant medication for their ADHD.
It’s also a good option for people who are at risk for abuse or dependence on stimulant medications.
Qelbree (viloxazine), a selective norepinephrinereuptake inhibitor, is an extended-release medication.
Less commonly, a doctor may prescribe a medication like the antidepressantWellbutrin (bupropion)to treat ADHD.
Bupropion is not formally FDA-approved for treating ADHD.
Be sure that your doctor or healthcare professional is experienced specifically with ADHD.
Get our printable guide for your next doctor’s appointment to help you ask the right questions.
2012;66(6).
2019;19(7).
2020;25(12).
2013;5(6).
doi:10.1016/j.jecm.2013.10.010
Food and Drug Administration.Highlights of prescribing information: Dyanavel XR (amphetamine).
Food and Drug Administration.Strattera highlights of prescribing information.
2018;90(1).
Gluud C, ed.PLOS ONE.
2017;12(7).
doi:10.1371/journal.pone.0180355
Food and Drug Administration.Qelbree highlights of prescribing information.
Ng QX.A systematic review of the use of bupropion for attention-deficit/hyperactivity disorder in children and adolescents.J Child Adolesc Psychopharmacol.
2017;27(2).
2014;24(9).
doi:10.1007/s00787-014-0661-5
De Sousa A, Kalra G.Drug therapy of attention deficit hyperactivity disorder: Current trends.Mens Sana Monogr.
2012;10(1):45-69. doi:10.4103/0973-1229.87261
National Institute of Mental Health.Attention-deficit hyperactivity disorder: Treatment and therapies.
